Protein kinase Cι mediates immunosuppression in lung adenocarcinoma
- 16 November 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (671) , eabq5931
Abstract
Lung adenocarcinoma (LUAD) is the most prevalent form of non–small cell lung cancer (NSCLC) and a leading cause of cancer death. Immune checkpoint inhibitors (ICIs) of programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) signaling induce tumor regressions in a subset of LUAD, but many LUAD tumors exhibit resistance to ICI therapy. Here, we identified Prkci as a major determinant of response to ICI in a syngeneic mouse model of oncogenic mutant Kras / Trp53 loss (KP)–driven LUAD. Protein kinase Cι (PKCι)–dependent KP tumors exhibited resistance to anti–PD-1 antibody therapy (α-PD-1), whereas KP tumors in which Prkci was genetically deleted (KPI tumors) were highly responsive. Prkci- dependent resistance to α-PD-1 was characterized by enhanced infiltration of myeloid-derived suppressor cells (MDSCs) and decreased infiltration of CD8 + T cells in response to α-PD-1. Mechanistically, Prkci regulated YAP1-dependent expression of Cxcl5 , which served to attract MDSCs to KP tumors. The PKCι inhibitor auranofin inhibited KP tumor growth and sensitized these tumors to α-PD-1, whereas expression of either Prkci or its downstream effector Cxcl5 in KPI tumors induced intratumoral infiltration of MDSCs and resistance to α-PD-1. PRKCI expression in tumors of patients with LUAD correlated with genomic signatures indicative of high YAP1-mediated transcription, elevated MDSC infiltration and low CD8 + T cell infiltration, and with elevated CXCL5 / 6 expression. Last, PKCι-YAP1 signaling was a biomarker associated with poor response to ICI in patients with LUAD. Our data indicate that immunosuppressive PKCι-YAP1-CXCL5 signaling is a key determinant of response to ICI, and pharmacologic inhibition of PKCι may improve therapeutic response to ICI in patients with LUAD.Keywords
This publication has 76 references indexed in Scilit:
- Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary TumorPLOS Biology, 2011
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Protein kinase C iota in the intestinal epithelium protects against dextran sodium sulfate-induced colitisInflammatory Bowel Diseases, 2011
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancersGenome Biology, 2011
- Protein kinase Cι expression and oncogenic signaling mechanisms in cancerJournal of Cellular Physiology, 2010
- Protein Kinase Cι Is Required for Pancreatic Cancer Cell Transformed Growth and TumorigenesisCancer Research, 2010
- Atypical Protein Kinase Cι Is Required for Bronchioalveolar Stem Cell Expansion and Lung TumorigenesisCancer Research, 2009
- MEME SUITE: tools for motif discovery and searchingNucleic Acids Research, 2009
- Atypical Protein Kinase Cι Expression and Aurothiomalate Sensitivity in Human Lung Cancer CellsCancer Research, 2008
- Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancerOncogene, 2008